Search Within

Joachim Yahalom

  1. "Ariela Noy"
Formats
  1. Meeting Abstract (36)
  2. Journal Article (32)
  3. Research Letter (2)
  4. Review (1)
Groups
  1. Center for Hematologic Malignancies (71)
  2. Department of Medicine (71)
  3. Hematologic Malignancies, Division of (71)
  4. Lymphoma (71)
  5. Radiation Oncology, Department of (71)
  6. Survivorship Research (71)

More Groups

People
  1. Ariela Noy (71)
  2. Andrew Zelenetz (60)
  3. David Straus (52)
  4. Steven Horwitz (45)
  5. Paul Hamlin (44)
  6. Alison Moskowitz (38)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (8)
  4. 2022 (3)
  5. 2021 (7)
  6. 2020 (6)

More Years

Publications
  1. Blood (31)
  2. Hematological Oncology (8)
  3. Journal of Clinical Oncology (7)
  4. Blood Advances (6)
  5. British Journal of Haematology (4)
  6. Haematologica (3)

More Publications

Publishers
  1. American Society of Hematology (37)
  2. Wiley Blackwell (8)
  3. American Society of Clinical Oncology (7)
  4. Elsevier Inc. (4)
  5. John Wiley & Sons (4)
  6. Ferrata Storti Foundation (3)

More Publishers

Results (71)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R.; Budde, E.; Barr, P. M.; Batlevi, C. L.; Chen, R.; Constine, L. S.; Courtien, A. I.; Dandapani, S. V.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Baseline metabolic tumor volume is an independent prognostic factor for relapsed and refractory Hodgkin lymphoma patients receiving PET-adapted salvage therapy with brentuximab vedotin and augmented ICE
    Meeting Abstract

    Moskowitz, A. J.; Schöder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • PET-adapted therapy with brentuximab vedotin and augmented ICE for relapsed/refractory Hodgkin lymphoma - Lack of Improvement with 3 versus 2 cycles of weekly brentuximab vedotin
    Meeting Abstract

    Moskowitz, A. J.; Schöder, H.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Journal Article

    Kumar, A.; Casulo, C.; Yahalom, J.; Schöder, H.; Barr, P. M.; Caron, P.; Chiu, A.; Constine, L. S.; Drullinsky, P.; Friedberg, J. W.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Long-term outcome of 490 patients with early-stage extra-nodal marginal zone lymphoma
    Meeting Abstract

    Yahalom, J.; Teckie, S.; Qi, S.; Hsu, M.; Lovie, S.; Chelius, M.; Noy, A.; Portlock, C.
    Haematologica (2015)

    Fulltext@MSK | Save
  • Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent
    Journal Article

    Teckie, S.; Qi, S.; Lovie, S.; Navarrett, S.; Hsu, M.; Noy, A.; Portlock, C.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2015)

    Fulltext@MSK | Save
  • PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: A non-randomised, open-label, single-centre, phase 2 study
    Journal Article

    Moskowitz, A. J.; Schöder, H.; Yahalom, J.; Mccall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Yahalom, J.; Schoder, H.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; Hamilton, A.; Hamlin, P.; Horwitz, S. M.; Jacob, A. G.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • FDG-PET adapted sequential therapy with brentuximab vedotin and augmented ICE followed by autologous stem cell transplant for relapsed and refractory Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A.; Schoder, H.; Gerecitano, J. F.; Hamlin, P.; Horwitz, S. M.; Matasar, M. J.; Keskinyan, V. S.; McCall, S.; Noy, A.; Palomba, M. L.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Successful management of gastric perforation in stage IV diffuse large B-cell lymphoma with chemoradiation therapy, percutaneous endoscopy gastrostomy for gastric drainage, and percutaneous endoscopy jejunostomy for nutrition
    Journal Article

    Khadraoui, H.; Feigin, K. N.; Fox, J. J.; Ong, L.; Shike, M.; Yahalom, J.; Noy, A.
    Clinical Lymphoma, Myeloma and Leukemia (2013)

    Fulltext@MSK | Save